.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Teva
Healthtrust
Cantor Fitzgerald
Express Scripts
Chubb
McKesson
UBS
Chinese Patent Office
Federal Trade Commission

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021163

« Back to Dashboard
NDA 021163 describes INFUVITE ADULT, which is a drug marketed by Sandoz Inc and is included in two NDAs. It is available from one supplier. Additional details are available on the INFUVITE ADULT profile page.

The generic ingredient in INFUVITE ADULT is alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k profile page.

Summary for NDA: 021163

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A PALMITATE','VITAMIN K') AND hsdb_dru' at line 1
Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1